Global pyrogen testing market worth USD 1,107.0 million by 2021, growing at a CAGR of 12.2% during 2015 and 2021.
The report covers future forecast and in-depth analysis for the pyrogen testing market on a global and regional level. The study put forward the valuable historic data of 2015 along with a considered forecast from 2016 to 2021 based on revenue (USD Billion). The study provides various drivers and restraints factors affecting the growth of pyrogen testing market along with their impact they have on the demand over the forecast period. Additionally, the report also provides the detailed study of opportunities which are available in the pyrogen testing market on a global level.
This report includes comprehensive coverage on global pyrogen testing market along with numerous current market trends, drivers, and restraints of pyrogen testing market. This report also covers a detailed description, competitive scenario and wide product portfolio of key vendors. To report also aware the competitive landscape in the market, an examination of Porter’s five forces model are also done for the pyrogen testing market. The study encompasses a market attractiveness analysis, wherein each type segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary as well as primary research team of various industry experts.
The study also includes a critical view on segmenting the global pyrogen testing market on the basis of test type, product type, application and five regions. All the segments have been analyzed on the basis of present and future trends and the market is estimated for the time period 2015 to 2021. The product type segment analyzed under this study includes instrument, services, and kits & reagents. The test type segmentation includes in vitro, LAL test and rabbit test. The application type market segmentation includes pharmaceutical & biotechnology, medical devices and others application. The regional segmentation includes the current and forecast demand for North America, Europe, Latin America, Asia-Pacific and the Middle East and Africa.
The major players in the pyrogen testing market include Thermo Fisher Scientific, Inc., Associates of Cape Cod, Inc., Charles River Laboratories, Inc., Ellab A/S, Genscript, Hyglos GmbH, Lonza Group, Merck Kgaa, WUXI Pharmatech (Cayman) Inc. and Wako Chemicals Usa, Inc.
This report segments the global pyrogen testing market as follows:
Global Pyrogen Testing Market: Product Segment Analysis
Global Pyrogen Testing Market: Test Analysis
Global Pyrogen Testing Market: Application Analysis
Global Pyrogen Testing Market: Regional Analysis
This report is based on in-depth qualitative and quantitative analyses of the global Pyrogen Testing market. Zion Research has collected and analyzed key data belong to the global Pyrogen Testing market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Pyrogen Testing across the world has been calculated through primary and secondary research.
Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Pyrogen Testing industry. Primary research makes up the major source of data collection and validation.
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Pyrogen Testing market.
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
Pyrogen comprises a diverse group of fever-causing substances. It constitutes both microbial and non-microbial substances. The most potent and most widely known pyrogens are the endotoxins or lipopolysaccharides (LPS), which are cell wall components of gram-negative bacteria. Gram-positive bacteria are also sources of pyrogen, in particular, lipoteichoic acid (LTA), particles from yeasts and viruses. Non-microbial pyrogen often comes from production site of the various manufacturing site. Small particles of packaging materials are a typical example of non-microbial pyrogen. Pyrogen contaminations in pharmaceutical products, bio-therapeutics and on medical devices can bring life-threatening fever, as a result it is mandatory for manufacturers to ensure that the pyrogen concentrations in pharmaceuticals product do not exceed certain limits.
The market for global pyrogen testing has been accelerated by the recent developments of pharmaceutical and biotechnological industry across different parts of the world. Moreover, the rise in a number of the launch of new drugs in the market coupled with the huge investment in research and development of drugs is the driving factor for the growth of pyrogen testing market. Furthermore, growing intervention of government in pharmaceutical industries is expected to fuel the growth of global pyrogen testing market. However, the highly consolidated pharmaceutical industry can restrict the growth of pyrogen testing market. Nonetheless, untapped market/developing countries market are considered as a major opportunity for upcoming growth of pyrogen testing market.
Based on product, pyrogen testing market is classified into three types: instruments, services, kits, and reagents. In general, all three segments play a very important role in pyrogen testing market. But in 2015, kits and reagent contributed maximum market share in terms of revenue followed by service and instrument. Limulus Amebocyte Lysate test (LAL test) kit is a great example of kits and reagent in pyrogen testing market. Greater demand for LAL test kit is due to ease of handling coupled with accurate result. The Limulus Amebocyte Lysate test recommended in international pharmacopoeias as the method for detecting bacterial toxins both in the raw materials used for the production of medicines and for the final products.
Based on the type of test, pyrogen testing market is classified into three types: in vitro test, LAL test and rabbit test. These entire tests play a very keen role in the management of pyrogen testing market. However, in 2015, LAL test dominated the pyrogen testing market due to various advantages over another test. Certain advantage of rabbit test includes:
LAL (Limulus Amebocyte Lysate) method has largely replaced the rabbit test in pyrogen testing market. In rabbit test, rabbits are not only used in the experiments that are conducted in research, but also in the pharmaceutical and food industry as well as other industries. Limulus Amebocyte Lysate test (LAL test) kit is a great example of kits and reagent in pyrogen testing market. Greater demand for LAL test kit is due to ease of handling coupled with accurate result.
Based on application, pyrogen testing market is classified into three types pharmaceutical & biotechnology, medical device and other applications. Application segment was dominated by pharmaceutical and biotechnology in 2015 due to rapidly increasing pharmaceutical and biotechnology industries and an increasing number of new biologics products. In addition, the launching of new biological drugs is considered as the most important growth driver for this segment during the forecast period.
Based on geography, pyrogen testing market is classified into five regions North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America was dominating the regional market for pyrogen testing in 2015, due to the huge investment in research and development of drugs. In addition, North America holds maximum business centre/headquarters of world premium pharmaceutical industries across the world. Growing business in Asia Pacific serves as a fastest growing regional market for pyrogen testing owing to the huge capital investment in research and manufacturing of medicine. The shift of medical business from west to east, especially in China and India, is a mean cause for the growth in the Asia Pacific region within the forecast period. Moreover, Latin America and the Middle East & Africa are also expected to have good growth due to growth in the medical tourism sector within the forecast period.
The major players in the pyrogen testing market include Associates of Cape Cod, Inc., Charles River Laboratories, Inc., Ellab A/S, Genscript, Hyglos GmbH, Lonza Group, Merck Kgaa, Thermo Fisher Scientific, Inc., WUXI Pharmatech (Cayman) Inc. and Wako Chemicals Usa, Inc.